Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome

Human Reproduction

Volumn 27, Issue 7, 2012, Pages 2082-2088

  Moran, L J ^a,b   Deeks, A A ^b   Gibson Helm, M E ^a,b   Teede, H J ^a,b,c  

^a MONASH UNIVERSITY   (Australia)

^b Jean Hailes for Women's Health   (Australia)

^c Diabetes Unit   (Australia)

Author keywords

anxiety; depression; phenotypes; polycystic ovary syndrome; quality of life

Indexed keywords

SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ANXIETY; ANXIETY DISORDER; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE SEVERITY; EMOTIONALITY; FEMALE; FEMALE INFERTILITY; GROUPS BY AGE; HAIR; HUMAN; HYPERANDROGENISM; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; MENSTRUATION DISORDER; MENTAL DISEASE; OBESITY; OBSERVATIONAL STUDY; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PREMENOPAUSE; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 84863573030     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/des114     Document Type: Article

References (42)

1. Avery JC, Braunack-Mayer AJ. The information needs of women diagnosed with polycystic ovarian syndrome-implications for treatment and health outcomes. BMC Womens Health 2007;1:9.
2. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;6:2745-2749. (Pubitemid 38766360)
3. Barnard L, Ferriday D, Guenther N, Strauss B, Balen AH, Dye L. Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod 2007;8:2279-2286. (Pubitemid 47241876)
4. Barry JA, Kuczmierczyk AR, Hardiman PJ. Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod 2011;9:2442-2451.
5. Benson S, Hahn S, Tan S, Mann K, Janssen OE, Schedlowski M, Elsenbruch S. Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany. Hum Reprod 2009;6:1446-1451.
6. Bradshaw AJ, Horwath CC, Katzer L, Gray A. Non-dieting group interventions for overweight and obese women: what predicts non-completion and does completion improve outcomes? Public Health Nutr 2010;13:1622-1628.
7. Clarke DM, Currie KC. Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence. Med J Aust 2009;7(Suppl):S54-S60.
8. Clayton WJ, Lipton M, Elford J, Rustin M, Sherr L. A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome. Br J Dermatol 2005;5:986-992. (Pubitemid 40704940)
9. Cronin L, Guyatt G, Griffith L, Wong E, Azziz R, Futterweit W, Cook D, Dunaif A. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 1998;6:1976-1987. (Pubitemid 28496325)
10. Deeks AA, Gibson-Helm ME, Teede HJ. Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil Steril 2010;7:2421-2423.
11. Deeks AA, Gibson-Helm ME, Paul E, Teede HJ. Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression? Hum Reprod 2011;6:1399-1407.
12. Department of Reproductive Health and Research WHO. Mental Health Aspects of Women's Reproductive Health: a Global Review of the Literature. Geneva, Switzerland:World Health Organization Press, 2009.
13. Diamanti-Kandarakis E, Panidis D. Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol 2007;5:735-742. (Pubitemid 47620439)
14. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999;11:4006-4011. (Pubitemid 30644187)
15. Espinó s JJ, Calaf J, Estadella J, Checa MA. Hirsutism scoring in polycystic ovary syndrome: concordance between clinicians' and patients' self-scoring. Fertil Steril 2010;94:2815-2816.
16. Farrell K, Antoni MH. Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil Steril 2010;5:1565-1574.
17. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-1447.
18. Goldney RD, Phillips PJ, Fisher LJ, Wilson DH. Diabetes, depression, and quality of life: a population study. Diabetes Care 2004;5: 1066-1070. (Pubitemid 38579767)
19. Hahn S, Janssen OE, Tan S, Pleger K, Mann K, Schedlowski M, Kimmig R, Benson S, Balamitsa E, Elsenbruch S. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol Euro Fed Endocr Soc 2005;6:853-860. (Pubitemid 43020236)
20. Harris-Glocker M, Davidson K, Kochman L, Guzick D, Hoeger K. Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin. Fertil Steril 2010;3:1016-1019.
21. Hoeger K, Davidson K, Kochman L, Cherry T, Kopin L, Guzick DS. The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials. J Clin Endocrinol Metab 2008;11:4299-4306. (Pubitemid 352789525)
22. Kitzinger C, Willmott J. 'The thief of womanhood': women's experience of polycystic ovarian syndrome. Soc Sci Med 2002;3:349-361. (Pubitemid 34028117)
23. Liang YL, Teede H, Kotsopoulos D, Shiel L, Cameron JD, Dart AM, McGrath BP. Non-invasive measurements of arterial structure and function: repeatability, interrelationships and trial sample size. Clin Sci 1998;6:669-679. (Pubitemid 29034431)
24. MarchWA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 2:544-551.
25. Moore M, Hofer S, McGee H, Ring L. Can the concepts of depression and quality of life be integrated using a time perspective? Health Qual Life Outcomes 2005;3:1.
26. Moran L, Teede H. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod Update 2009;4:477-488.
27. Moran LJ, Noakes M, Clifton PM, Wittert GA, Williams G, Norman RJ. Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome. Am J Clin Nutr 2006;1:77-87. (Pubitemid 44699174)
28. Moran L, Gibson-Helm M, Teede H, Deeks A. Polycystic ovary syndrome: a biopsychosocial understanding in young women to improve knowledge and treatment options. J Psychosom Obstet Gynaecol 2010a;1:24-31.
29. Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 2010b;4:347-363.
30. Moran LJ, Strauss BJ, Teede HJ. Diabetes risk score in the diagnostic categories of polycystic ovary syndrome. Fertil Steril 2011;5:1742-1748.
31. Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet 2007;9588:685-697. (Pubitemid 47285318)
32. Palomba S, Falbo A, Russo T, Tolino A, Orio F, Zullo F. Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. Fertil Steril 2010;5:1805-1811.
33. Pekhlivanov B, Kolarov G, Kavurdzhikova S, Stoikov S. [Determinants of health related quality of life in women with polycystic ovary syndrome]. Akusherstvo i ginekologiia 2006;7:29-34.
34. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;1:41-47.
35. Roy-Byrne PP, Davidson KW, Kessler RC, Asmundson GJ, Goodwin RD, Kubzansky L, Lydiard RB, Massie MJ, Katon W, Laden SK et al. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry 2008; 3:208-225. (Pubitemid 351545834)
36. Teixeira PJ, Going SB, Houtkooper LB, Cussler EC, Metcalfe LL, Blew RM, Sardinha LB, Lohman TG. Pretreatment predictors of attrition and successful weight management in women. Int J Obes Relat Metab Disord 2004;9:1124-1133. (Pubitemid 39141550)
37. Thomson RL, Buckley JD, Lim SS, Noakes M, Clifton PM, Norman RJ, Brinkworth GD. Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome. Fertil Steril 2010;5:1812-1816.
38. Wadden TA, Butryn ML, Sarwer DB, Fabricatore AN, Crerand CE, Lipschutz PE, Faulconbridge L, Raper SE, Williams NN. Comparison of psychosocial status in treatment-seeking women with class III vs. class I-II obesity. Obesity (Silver Spring) 2006;14(Suppl 2):90S-98S.
39. Weiner CL, Primeau M, Ehrmann DA. Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls. Psychosom Med 2004;3:356-362. (Pubitemid 38668404)
40. Wilhelm K, Mitchell P, Slade T, Brownhill S, Andrews G. Prevalence and correlates of DSM-IV major depression in an Australian national survey. J Affect Disord 2003;2:155-162. (Pubitemid 36645248)
41. Zawadzki J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Marrian GR (eds). Polycystic Ovary Syndrome Current Issues in Endocrinology and Metabolism. Boston, USA: Blackwell Scientific, 1992, 377-384.
42. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;6:361-370. (Pubitemid 13098606)